Radiology/Medical Imaging

Pharmaceutical clinical trials involving sophisticated medical imaging endpoints are growing in number. In addition, radiology device and diagnostics trials are fast-growing too.

Our clinical team includes a board-certified specialist radiologist, who brings a wealth of expertise in using medical imaging research to assist with correct trial design and strategy.

We specialise in various imaging modalities, including:
  • MRI
  • fMRI
  • CT
  • PET
  • Ultrasound
  • Fluoroscopy

We understand the importance of reliable image acquisition, interpretation, and centralised reading processes required to ensure the validity of imaging endpoints.

Disciplined,

Cost-Efficient Execution

while maintaining the Highest Quality

Local Trials,

Global Approvals

Access FDA Regulatory Expertise

Our Clinical Team has over

120

years

of Combined Clinical Trial Experience

Addressing Common Pain Points Associated with Radiology/Medical Imaging Clinical Trials 

It can be challenging to find and keep patients who meet the specific criteria for radiology and imaging studies, leading to delays and increased costs.

iNGENū CRO addresses this pain point with Enhanced Recruitment Strategies

We employ a comprehensive patient-centric approach, leveraging advanced data analytics and partnerships with healthcare institutions, ensuring faster recruitment and higher retention rates tailored for imaging studies.

Ensuring that imaging data is consistently of high quality across multiple sites, equipment, and operators is a challenge, especially in multi-centre trials. Poor-quality images or inconsistencies can lead to erroneous conclusions.

iNGENū addresses this pain point with •    Advanced Data Management and Quality Control Systems

Using state-of-the-art AI-driven platforms and standardisation tools, iNGENū ensures that imaging data is of the highest quality, with minimised variability, irrespective of the collection site.

Radiology and medical imaging trials have strict regulatory requirements, especially around radiation exposure. Navigating these regulations and ensuring continuous compliance can be challenging.

iNGENū addresses this pain point with Dedicated Regulatory and Compliance Teams

Our team consistently stays informed about the most recent regulatory updates and guidelines. With iNGENū, clients can be assured of streamlined regulatory navigation and continuous adherence to all compliance mandates.

Different sites may use various imaging equipment or have different protocols for imaging, which can introduce variability in the data.

iNGENū addresses this pain point with Standardised Imaging Protocols and Technology Harmonisation

We work closely with trial sites to implement standardised imaging protocols and offer technology harmonisation solutions, ensuring consistent data regardless of the equipment or site.

The sheer volume of imaging data generated can pose significant challenges in terms of storage, transfer, and analysis.

iNGENū addresses this pain point with Advanced Data Management Systems

Our state-of-the-art data management platform ensures secure storage, seamless transfer, and efficient analysis of large imaging datasets.

The iNGENū CRO Difference

iNGENu - FDA
Local Trials, Global Approvals

We uniquely combine Australian expertise with direct FDA submission capabilities, offering a streamlined path for sponsors to achieve global approval. Our seamless integration allows trial data from Australia to be submitted directly to the FDA via our E-Gateway, eliminating the need for third-party intermediaries.

iNGENu - cost efficient
Disciplined, Cost-Efficient Execution

iNGENū CRO takes a highly strategic and disciplined approach to clinical research, ensuring that every dollar is directed toward generating meaningful outcomes. Our trials are designed with efficiency in mind, eliminating unnecessary costs while maintaining the highest scientific and regulatory standards.

iNGENu - APAC
Australian-Headquartered, Asia-Pacific Reach

We provide sponsors with comprehensive trial capabilities across the Asia-Pacific region, offering a seamless combination of cost-efficiency and high-quality clinical trials. We leverage the region's competitive pricing while maintaining rigorous Australian-based project management and clinical oversight.

"We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have used iNGENū for: Medical writing, project management, clinical data management and full end-to-end, clinical trial execution and monitoring.

We have been very happy with all aspects of the management of the clinical trial and have been particularly impressed by the out-of-the-box creative solutions to speed up and reduce overheads for our company during this clinical trial."

Giles Moss
Chief Executive Officer

iNGENu testimonial-logos-monotone-1

Ready to discuss your Radiology/Medical Imaging Clinical Trial?